Bavarian Nordic announced today that its vaccine, JYNNEOS, has been licensed by ...
McKesson has planned to enhance its oncology platform with a significant investm...
It appears that restructuring is the trend for many big pharmaceutical companies...
Germany has provided 100,000 doses of the Mpox vaccine from its armed forces to ...
Kidney disease biotech Pathalys Pharma has raised $105 million in a Series B fun...
Eli Lilly’s weight loss drug, tirzepatide, has shown a 94% reduction in the inci...
Ascendis Pharma should be in a good position to launch its hormone replacement t...
Pfizer reported top-line interim safety and immunogenicity outcomes from Substud...
Lykos Therapeutics said that the U.S. Food and Drug Administration (FDA) has rej...
Following its approval earlier this week and the scheduled withdrawal of Takeda’...
Servier has enriched its portfolio of IDH-targeted drugs for next year thanks to...
Novo Nordisk has decided to discontinue the development of a medication candidat...
Neuralink, founded by Elon Musk, revealed that it has placed its device in the s...
Vertex and CRISPR Therapeutics are making headway on the difficult path to assur...
American-based specialty pharmaceutical company Mallinckrodt has undertaken the ...
In spite of the fact that it failed to meet the primary goal in a pediatric rese...
